- Home
- SOPH vs SABA Comparison
SOPH vs SABA Comparison
Compare SOPH & SABA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SOPH
- SABA
- Stock Information
- Founded
- SOPH 2011
- SABA 1988
- Country
- SOPH Switzerland
- SABA United States
- Employees
- SOPH N/A
- SABA N/A
- Industry
- SOPH Biotechnology: Biological Products (No Diagnostic Substances)
- SABA
- Sector
- SOPH Health Care
- SABA
- Exchange
- SOPH Nasdaq
- SABA Nasdaq
- Market Cap
- SOPH 226.6M
- SABA 246.4M
- IPO Year
- SOPH 2021
- SABA N/A
- Fundamental
- Price
- SOPH $3.26
- SABA $8.87
- Analyst Decision
- SOPH Strong Buy
- SABA
- Analyst Count
- SOPH 3
- SABA 0
- Target Price
- SOPH $7.00
- SABA N/A
- AVG Volume (30 Days)
- SOPH 21.3K
- SABA 290.0K
- Earning Date
- SOPH 11-05-2024
- SABA 01-01-0001
- Dividend Yield
- SOPH N/A
- SABA 12.91%
- EPS Growth
- SOPH N/A
- SABA N/A
- EPS
- SOPH N/A
- SABA N/A
- Revenue
- SOPH $64,488,000.00
- SABA N/A
- Revenue This Year
- SOPH $7.20
- SABA N/A
- Revenue Next Year
- SOPH $15.71
- SABA N/A
- P/E Ratio
- SOPH N/A
- SABA N/A
- Revenue Growth
- SOPH 9.85
- SABA N/A
- 52 Week Low
- SOPH $2.70
- SABA $3.64
- 52 Week High
- SOPH $7.37
- SABA $4.42
- Technical
- Relative Strength Index (RSI)
- SOPH 46.64
- SABA 49.76
- Support Level
- SOPH $3.06
- SABA $8.73
- Resistance Level
- SOPH $3.47
- SABA $9.14
- Average True Range (ATR)
- SOPH 0.18
- SABA 0.15
- MACD
- SOPH -0.00
- SABA -0.03
- Stochastic Oscillator
- SOPH 45.45
- SABA 32.27
About SOPH SOPHiA GENETICS SA
Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.
About SABA Saba Capital Income & Opportunities Fund II Shares of Beneficial Interest
Templeton Global Income Fund is a closed-end fund. It seeks high current income, with a secondary goal of capital appreciation. Under normal market conditions. The Fund invests at least over 80% of its net assets in income-producing securities, including debt securities of the United States and foreign issuers, including emerging markets.